Antibiotic Guideline Gaps Raise SSI Risk
-
By
-
mdspire news news staff
-
March 3, 2026
-
3 min
By
mdspire news news staff
March 3, 2026
Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.
June 16, 2026